Bill Search

HB 3717
  • Introduced
    Mar 04, 2025
  • Passed House
  • Passed Senate
  • Signed into Law
HB 3717
Texas House Bill
Did you know we offer free bill tracking in Congress and 50 states, and a great mobile app? Sign up here
Relating to the establishment of a grant program to fund the United States Food and Drug Administration's drug development trials with ibogaine for the purpose of securing the administration's approval as a medication for treatment of opioid use disorder, co-occurring substance use disorder, and any other neurological or mental health conditions for which ibogaine demonstrates efficacy.
Last Action See all actions
House • Apr 25, 2025: Committee report sent to Calendars
Latest Bill Text See all bill texts
House Committee Report

Summary/Bill Text

Comments on HB 3717

Tweets

Whip Lists

Sponsors
Votes
Looks like there aren't any voting records available at this moment.
Actions
  • Apr 25, 2025 | House
    • Committee report sent to Calendars
  • Apr 23, 2025 | House
    • Comte report filed with Committee Coordinator
    • Committee report distributed
  • Apr 14, 2025 | House
    • Considered in public hearing
    • Reported favorably w/o amendment(s)
  • Apr 07, 2025 | House
    • Scheduled for public hearing on . . . 04/07/2025
    • Considered in public hearing
    • Testimony taken/registration(s) recorded in committee
    • Left pending in committee
  • Mar 26, 2025 | House
    • Read first time
    • Referred to Public Health
  • Mar 04, 2025 | House
    • Filed
Bill Texts
Documents
Sources